Evidence of serotonin-dopamine involvement in the inhibition of d-amphetamine stereotypy and appearance of stereotyped movements found respectively after acute and long-term treatment with morphine and methadone in rats.
D000818:Animals; D001921:Brain / Q000502:physiology; D003913:Dextroamphetamine / Q000494:pharmacology*; D004298:Dopamine / Q000502:physiology*; D010134:Fenclonine / Q000494:pharmacology; D005277:Fenfluramine / Q000494:pharmacology; D006220:Haloperidol / Q000494:pharmacology; D006801:Humans; D008297:Male; D008691:Methadone / Q000494:pharmacology*; D008774:Methylphenidate / Q000494:pharmacology; D009020:Morphine / Q000494:pharmacology*; D010879:Piperazines / Q000494:pharmacology; D051381:Rats; D012701:Serotonin / Q000502:physiology*; D013239:Stereotyped Behavior / Q000187:drug effects*
D010879:Piperazines; D008774:Methylphenidate; D005277:Fenfluramine; D012701:Serotonin; D009020:Morphine; D006220:Haloperidol; D010134:Fenclonine; C015068:1-(3-chlorophenyl)piperazine; D003913:Dextroamphetamine; D008691:Methadone; D004298:Dopamine